APA (7th ed.) Citation

Jung, S., Kim, Y., Jo, M., Son, J., Ju, J., Park, M., . . . Ahn, D. (2025). Can Botulinum Toxin Type E Serve as a Novel Therapeutic Target for Managing Chronic Orofacial Pain? Toxins, 17(3), 130. https://doi.org/10.3390/toxins17030130

Chicago Style (17th ed.) Citation

Jung, Sung-Koog, et al. "Can Botulinum Toxin Type E Serve as a Novel Therapeutic Target for Managing Chronic Orofacial Pain?" Toxins 17, no. 3 (2025): 130. https://doi.org/10.3390/toxins17030130.

MLA (9th ed.) Citation

Jung, Sung-Koog, et al. "Can Botulinum Toxin Type E Serve as a Novel Therapeutic Target for Managing Chronic Orofacial Pain?" Toxins, vol. 17, no. 3, 2025, p. 130, https://doi.org/10.3390/toxins17030130.